Cita APA (7a ed.)

Almejún, M. B., Giordano, M. N., Gamberale, R., & Borge, M. (2017). The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.

Cita Chicago Style (17a ed.)

Almejún, María Belén, Mirta Nilda Giordano, Romina Gamberale, y Mercedes Borge. The Kinase Inhibitors R406 and GS-9973 Impair T Cell Functions and Macrophage-mediated Anti-tumor Activity of Rituximab in Chronic Lymphocytic Leukemia Patients. 2017.

Cita MLA (8a ed.)

Almejún, María Belén, et al. The Kinase Inhibitors R406 and GS-9973 Impair T Cell Functions and Macrophage-mediated Anti-tumor Activity of Rituximab in Chronic Lymphocytic Leukemia Patients. 2017.